Lazard Asset Management’s Inspire Medical Systems INSP Stock Holding History
Bought
Maintained
Sold
Other funds holding INSP
Lazard Asset Management's INSP Position: Q3 2026 in Review
Lazard Asset Management increased its Inspire Medical Systems (INSP) stake by 29% in Q3 2026, buying an estimated $379K and bringing the position to 28,185 shares worth $1.95M. The position accounts for ﹤0.01% of the portfolio, ranked #969.
Lazard Asset Management first reported a position in INSP in Q1 2020 and has held it in 25 quarters since. The position peaked at $15.2M in Q3 2022. 307 funds tracked by Wall St. Rank hold INSP as of Q3 2026.
- Lazard Asset Management held 28,185 shares of Inspire Medical Systems worth $1.95M as of Q3 2026.
- Lazard Asset Management bought 6,345 Inspire Medical Systems shares in Q3 2026, an estimated $379K.
- Inspire Medical Systems made up ﹤0.01% of Lazard Asset Management's portfolio in Q3 2026, its #969 holding.
- Lazard Asset Management first reported a position in Inspire Medical Systems in Q1 2020 and has held it in 25 quarters since.
- Lazard Asset Management's Inspire Medical Systems position peaked at $15.2M in Q3 2022.
- 307 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2026.
Based on Lazard Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.